Company Overview and News

to your dashboard

Headline News

Large Opportunity For Smaller Arbitrageurs

2017-11-13 seekingalpha
The deal is very small with a total value of roughly $33MM, which will lead to very little institutional attention. (20-2)

BRIEF-Combimatrix Corp stockholders approve merger agreement with Invitae Corp

2017-11-10 reuters
* Combimatrix Corp says ‍approximately 1.79 million of common shares voting in meeting voted in favor of approval & adoption of all-stock merger agreement​ Source text for Eikon: Further company coverage: (20-0)

Biotech Forum Daily Digest: Redhill's Bungled Secondary

2017-11-09 seekingalpha
The biotech sector continues to head down this week as sentiment on the high beta areas of the market weaken. (159-1)

Invitae 2017 Q3 - Results - Earnings Call Slides

2017-11-07 seekingalpha
The following slide deck was published by Invitae in conjunction with their 2017 Q3 earnings call. (18-0)

Invitae's (NVTA) CEO Sean George on Q3 2017 Results - Earnings Call Transcript

2017-11-07 seekingalpha
Good afternoon. My name is Chris and I will be your conference operator today. At this time, I would like to welcome everyone to the Invitae's Third Quarter 2017 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. (18-0)

Invitae Corp to Host Earnings Call

2017-11-06 accesswire

Invitae's new framework for classifying genetic variants aims to improve consistency of genetic test results industry-wide

2017-10-05 prnewswire
Refinements to existing guidelines establish a more detailed and transparent approach for classifying variants at scale (18-0)

Atlas Genetics Appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer; Founding CEO Dr John Clarkson Steps Up to Executive Chairman

2017-10-03 prnewswire
Atlas Genetics Ltd., the ultra-rapid, point-of-care (POC) testing company for women's and family health, today announced that Jeffrey R. Luber has been appointed Chief Executive Officer effective 1 October 2017. Dr John Clarkson, current founding CEO, will become Executive Chairman and current chairman, Neil Butler, will remain with the Company as a non-executive director of the Board. (34-1)

BRIEF-CombiMatrix Corp says co's unit entered into Marketing and Laboratory Services Agreement with Invitae Corp and its unit

2017-09-27 reuters
* CombiMatrix Corp - ‍on Sept 25, co’s unit CombiMatrix Molecular Diagnostics Inc entered into marketing and laboratory services agreement with Invitae Corp and its unit (20-0)

CombiMatrix Sets Record Date And Special Stockholders Meeting Date Regarding Proposed Merger With Invitae

2017-09-25 devicespace
IRVINE, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) (“CombiMatrix” or the “Company”), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announced today it has set important dates for a special meeting of its stockholders to vote on matters related to the proposed merger with Invitae Corporation (“Invitae”). (35-0)

Invitae to Present at the Cantor Fitzgerald Global Healthcare Conference

2017-09-13 prnewswire
SAN FRANCISCO, Sept. 13, 2017 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that Katherine Stueland, chief commercial officer of Invitae, will present at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2017 at approximately 11:30 a.m. Eastern / 8:30 a.m. Pacific in New York City. (1-0)

Invitae highlighting new research, expanded suite of services at National Society of Genetic Counselors (NSGC) 36th Annual Conference

2017-09-13 prnewswire
-- Research highlights utility of proactive genetic screening in healthy adults -- -- Award-winning genetic information tool added to support use of genetic information as part of mainstream medical care throughout life -- (1-0)

MMCAP International Inc. SPC discloses 5.53% ownership in CBMX / CombiMatrix Corp. -

August 22, 2017 - MMCAP International Inc. SPC has filed an SC 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 161,469 shares of CombiMatrix Corp. (NASDAQ:CBMX). This represents 5.5322 percent ownership of the company.

3 Stocks Set to Pop

2017-08-16 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. (0-1)

Genetic testing firm Color expands beyond hereditary cancer - San Francisco Chronicle

2017-08-10 sfchronicle
Burlingame genetic testing company Color Genomics is adding a new test for hereditary high cholesterol — the firm’s first foray beyond the hereditary cancer field.

CUSIP: 46185L103